Target intelligence / Profile preview

Protocadherin alpha-C2 (PCDHAC2)

Target
PCDHAC2
Molecular classification
Cell adhesion molecule, Cadherin superfamily protein
01

Overview

Protocadherin alpha-C2 (PCDHAC2) is a member of the protocadherin alpha gene cluster, located on chromosome 5. It is a potential calcium-dependent cell adhesion protein integral to plasma membranes, predominantly expressed in neurons. Its structure comprises N-terminal exons encoding six cadherin ectodomains and C-terminal exons encoding the cytoplasmic domain shared across the cluster. PCDHAC2 plays a critical role in neural cell-cell adhesion, influencing the formation and maintenance of specific neuronal connections and axonal projections in the brain, particularly serotonergic axons. Mutations or dysregulation of PCDHAC2 are associated with abnormal neuronal circuit assembly and have been linked to autism spectrum disorder and altered serotonergic projections, which may correlate with depression-like phenotypes in animal models. It is not currently considered a direct therapeutic target or receptor in pharmacology, and no interacting drugs, validated biomarkers, or known safety concerns are reported in available databases.

Other names
Protocadherin alpha subfamily C, 2PCDHAC2PCDH-alpha-C2PCDH-ALPHA-C2protocadherin alpha-C2
02

Biological functions

Cell adhesionNeuronal connectivityAxonal tilingCalcium ion bindingEstablishment and maintenance of specific cell-cell connections in the brain
03

Disease associations

Neurodevelopmental/neuropsychiatric disorder (Autism spectrum disorder)Depression-like behaviors (based on mouse mutants)Other neurological circuit disorders

Beyond the preview

Go deeper on Protocadherin alpha-C2 (PCDHAC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protocadherin alpha-C2 (PCDHAC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call